Diabetes Devices
The U.S. diabetes device market continues to expand as diabetes prevalence rises and demand for continuous glucose monitoring, insulin delivery, and digital health solutions increases. Our research delivers comprehensive analysis of market dynamics, emerging technologies, competitive positioning, and future growth opportunities.
The U.S. Diabetes Care Devices Market is projected to expand from USD 18.78 billion in 2026 to USD 32.84 billion by 2032, advancing at a 9.76% CAGR. Expansion is driven by rapid continuous glucose monitoring adoption, automated insulin delivery platforms, tubeless patch pumps, over-the-counter metabolic biosensors, and streamlined pharmacy benefit adjudication, structurally displacing legacy fingerstick meters and manual injection syringes.
Read Report Details